Accolade, Performance

ACCDDelisted Stock  USD 7.02  0.00  0.00%   
The firm shows a Beta (market volatility) of 0.33, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Accolade,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Accolade, is expected to be smaller as well. Accolade, right now shows a risk of 0.0%. Please confirm Accolade, jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to decide if Accolade, will be following its price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Accolade, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Accolade, is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
  

Accolade, Relative Risk vs. Return Landscape

If you would invest  702.00  in Accolade, on October 3, 2025 and sell it today you would earn a total of  0.00  from holding Accolade, or generate 0.0% return on investment over 90 days. Accolade, is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Accolade,, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Accolade, Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Accolade,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Accolade,, and traders can use it to determine the average amount a Accolade,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ACCD
Based on monthly moving average Accolade, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Accolade, by adding Accolade, to a well-diversified portfolio.

Accolade, Fundamentals Growth

Accolade, Stock prices reflect investors' perceptions of the future prospects and financial health of Accolade,, and Accolade, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Accolade, Stock performance.

About Accolade, Performance

By analyzing Accolade,'s fundamental ratios, stakeholders can gain valuable insights into Accolade,'s financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Accolade, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Accolade, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people.

Things to note about Accolade, performance evaluation

Checking the ongoing alerts about Accolade, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Accolade, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Accolade, is not yet fully synchronised with the market data
Accolade, has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 414.29 M. Net Loss for the year was (99.81 M) with profit before overhead, payroll, taxes, and interest of 215.08 M.
Accolade, currently holds about 330.63 M in cash with (16.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6.
Over 88.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Investors in Niagen Bioscience have seen incredible returns of 320 percent over the past three years
Evaluating Accolade,'s performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Accolade,'s stock performance include:
  • Analyzing Accolade,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Accolade,'s stock is overvalued or undervalued compared to its peers.
  • Examining Accolade,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Accolade,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Accolade,'s management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Accolade,'s stock. These opinions can provide insight into Accolade,'s potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Accolade,'s stock performance is not an exact science, and many factors can impact Accolade,'s stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in Accolade, Stock

If you are still planning to invest in Accolade, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accolade,'s history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency